May 15, 2017 |
Regulating laboratory developed tests(LDTs) has been an FDA priority for years. Yet, in the wake of the November 2016 elections, FDA said it would suspend efforts to issue an LDT policy. Presumably, for at least the next four years, FDA will not seek to implement a policy governing the regulation of LDTs.
Food and Drug Law Institute